← Leaderboards
Soona Shin
Cincinnati Childrens Hosp Med Ctr
$3,489,019
Attributed
$4,437,070
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,437,070 · 2
By mechanism
R37$2,540,968 · 1
R01$1,896,102 · 1
Top collaborators
- Nikolai A Timchenko3 shared
Most similar at Cincinnati Childrens Hosp Med Ctr
Same institution · by research overlap
- Alexander Miethke$7,111,955
- James M Wells$16,596,466
- Rohit Kohli$5,277,307
- Vivian Hwa$2,125,267
- Jennifer Melissa Kaplan$3,243,182
Others in their field
Other Emerging Leaders on “Pathway Interactions”
- April Brinkoetter · Hungry Heart Media, Inc.$59,802,265
- Kevin Urdahl · Seattle Children'S Hospital$47,227,116
- Urs Ochsner · Crestone, Inc.$38,569,476
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Nader Fotouhi · Global Alliance For Tb Drug Development$28,468,137
- Jeffrey Glenn · Stanford University$26,017,226
Research focus
Pathway InteractionsCellsMolecularCirrhosisMalignant Neoplasm Of LiverAnimal ModelLiver DiseasesMediatingGene ExpressionFibrosisMouse ModelMalignant NeoplasmsLiverCell ProliferationHepatocyteHepatic Stellate CellAngiogenesisInnovationLabelFoxl1 GeneChronic Liver DiseaseExperimental ModelsFutureHepatocarcinogenesis
Grant awards (10)
The role of DNAJB1-PKAc-β-catenin axis in fibrolamellar HCC$637,299
R01 · FY2025 · CA
Pathogenic Role of Foxl1+ Hepatic Progenitor Cells in Fibrotic Liver Disease$370,131
R37 · FY2025 · CA · contact PI
The role of DNAJB1-PKAc-β-catenin axis in fibrolamellar HCC$618,809
R01 · FY2024 · CA
Pathogenic Role of Foxl1+ Hepatic Progenitor Cells in Fibrotic Liver Disease$359,547
R37 · FY2024 · CA · contact PI
The role of DNAJB1-PKAc-β-catenin axis in fibrolamellar HCC$639,994
R01 · FY2023 · CA
Pathogenic Role of Foxl1+ Hepatic Progenitor Cells in Fibrotic Liver Disease$356,438
R37 · FY2023 · CA · contact PI
Pathogenic Role of Foxl1+ Hepatic Progenitor Cells in Fibrotic Liver Disease$363,713
R37 · FY2022 · CA · contact PI
Pathogenic Role of Foxl1+ Hepatic Progenitor Cells in Fibrotic Liver Disease$363,713
R37 · FY2021 · CA · contact PI
Pathogenic Role of Foxl1+ Hepatic Progenitor Cells in Fibrotic Liver Disease$363,713
R37 · FY2020 · CA · contact PI
Pathogenic Role of Foxl1+ Hepatic Progenitor Cells in Fibrotic Liver Disease$363,713
R37 · FY2019 · CA · contact PI